Medical Devices Startups

A manufacturer of ultra-thin precision solutions for high-tech industries including semiconductors, medical technology, and optics, serving customers from product development through scalable cleanroom production.

1 investor

A biotech company developing gene therapy treatments for neurodegenerative diseases. The company is led by a founder with extensive clinical and regulatory experience in cell and gene therapy, supported by advisors and board members with deep expertise in neurosurgery, clinical neuroscience, and gene therapy development.

1 investor

Mach7 Technologies develops medical imaging software platforms and diagnostic viewers for healthcare enterprises, focusing on image workflow, data management, and artificial intelligence integration.

1 investor

machineMD develops technology to improve the measurement and early diagnosis of brain function and disorders. The company serves healthcare providers and patients seeking accurate, fast neurological diagnosis.

1 investor

Macro Biologics develops biotherapeutic products based on amino acid polymer technology for applications in therapeutics and diagnostics. The company serves the biopharmaceutical and medical device sectors.

1 investor

macu4 designs modular assistive devices for the hand and arm, including custom-made solutions, aimed at people needing aids for daily life, leisure, sport, and mobility. The systems are developed with specialists and users and configured step by step to fit individual needs.

1 investor

macu4 develops functional orthopedic medical devices and services designed to support daily, leisure, and sports activities with pragmatic, comfortable solutions. The company serves orthopedic patients and healthcare markets across the USA, EU, and Switzerland.

1 investor

Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.

1 investor

Made for Movement develops medical devices and rehabilitation technologies for people with physical disabilities to enable mobility and physical activity. The company serves patients, therapists, and healthcare facilities offering solutions for both home use and clinical rehabilitation settings.

1 investor

LeadCare II is a rapid blood test device that identifies lead exposure in children within 3 minutes using a fingerstick sample at the point of care. The product is designed for pediatric practices and healthcare providers to enable early diagnosis and prevent lead poisoning in children, particularly those in homes built before 1978.

1 investor

Magnendo develops a magnetically steerable soft-robotic guidewire system for neurovascular endovascular procedures, enabling physicians to access hard-to-reach targets in the brain's blood vessels for stroke and aneurysm treatment. The system is designed to reduce procedural time, complications, and costs while improving patient outcomes.

1 investor

Magnes AG, an ETH Zurich spinoff, develops NUSHU, a wearable sensor system with vibrotactile feedback and AI algorithms for medical-grade gait and human movement analysis. Its products serve consumers, healthcare professionals, and academic and clinical researchers tracking patient mobility in clinical and real-world settings.

1 investor

Magnisity develops a robotic guidance platform for lung endoscopy that uses patented disposable deformation sensors to provide real-time shape and location navigation inside the body, combining diagnosis and treatment in a single procedure. The system addresses CT-to-body divergence and supports simultaneous multi-device use for physicians performing minimally invasive procedures such as navigational bronchoscopy.

1 investor

Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course. The noninvasive, non-drug treatment was developed at Stanford's Brain Stimulation Lab and is delivered to patients through verified clinical providers.

1 investor

MagPlasma develops plasma-based technologies that replace conventional heat and chemical processes in applications including air purification, sterilization, and material processing. The company targets industries seeking cleaner and more energy-efficient alternatives to traditional methods.

1 investor

Maguro Surgical develops MagStone, a device that coats kidney stone fragments with a magnetic polymer to enable more complete stone removal with fewer passes and faster procedures. The company builds surgical tools for urologists and is designed to integrate with existing surgical workflows and equipment.

1 investor

MAK-SYSTEM develops blood and plasma management software for blood centers, transfusion services, tissue banks, and cell therapy laboratories worldwide. The company provides centralized digital solutions to manage collection, storage, and distribution of blood, plasma, and biological products.

1 investor

Makani Science develops a wearable patch sensor that continuously monitors respiratory function wirelessly and noninvasively for patients undergoing sedation, surgery, or managing chronic respiratory conditions. The device tracks respiratory rate, tidal volume, and minute ventilation in real-time via mobile platforms for healthcare professionals.

1 investor

Maman develops a microneedle-based medical device that replaces repeated self-injections and offers real-time hormonal monitoring using proprietary drug delivery technology. The company targets patients requiring frequent injections.

1 investor

Manometric develops custom-made orthotic braces and splints using 3D scanning and AI technology for better fit and comfort. The company serves patients and healthcare practitioners seeking personalized orthopedic solutions in the Netherlands.

1 investor

MantaBio builds an automated contamination and sterility testing platform for the drug supply chain, using a closed single-cartridge automated vPCR workflow (the MantaVision Automated vPCR Platform) for release and in-process microbial detection. It serves biopharma manufacturers, CDMOs, and clinical sites, deployable from the bioreactor floor to point-of-care manufacturing sites.

1 investor

MapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.

1 investor

MARAbio is a precision immunology company developing blood tests to identify Maternal Autoantibody Related Autism (MARA), a subtype estimated to represent up to 20% of autism diagnoses, alongside companion diagnostics and therapeutic antibody interventions for early detection and targeted treatment.

1 investor

Marbles Health develops EASE, a medically certified transcranial direct current stimulation (tDCS) neuromodulation headband that combines brain stimulation, EEG tracking, and cognitive-emotional training to treat conditions such as depression, anxiety, ADHD, addiction, and chronic pain. The device is used by psychiatrists and clinics in India and is CDSCO (Indian FDA) approved.

1 investor